It starts out as a trickle here and there, inconsistent,

New Post Public Reply Private Reply Replies (0) Message Board
WBeacham
265
It starts out as a trickle here and there, inconsistent, spotty, insignificant really. It might stop for a while, then resume. Avalanches start out this way. This pattern is consistent w/ the complexity of getting these individual business relationships off the ground; one-offs so-to-speak. The company struggles to get a 'study' approved, funded, populated, up-and-running, data evaluated, and finally, get it published. And later, another study ... and so on. The research and the studies continue, again, consistent w/ the sporadic nature of continually validating the science in the hope that one day it will be enough. I think we have reached that point. The 'word' is getting out, finally! Hundreds of hours go into each and every study completed and deal consummated. The snails' pace of modest successes is maddening and each one is labor intensive.

There doesn't appear to be any rhyme or reason but yet, YET !!, the money lenders continue to roll over the loans despite having the ability to demand payment; more than once. The COB Staelin continues to contribute money. IMO, this is a BIG tell, as in poker playing. The CEO has been 'chatty' w/ hints. And don't forget about Keith and Dr. Koneru; Just sayin, juuuussssst saaayyinnn'.

I think we will see an increase in 'news' as 2025 approaches. It could be a business deal, or maybe not. Maybe a news story that explains how popular this PEMF treatment is. No mention of BIEL, per sé, but those w/ 'eyes that can see' make the connection. Maybe a military connection is highlighted w/ the PEMF treatment. No mention of BIEL but the 'eyes' can see. I can see this RRx for vets (veterans) and pets really taking off. We love our pets and we love our vets. Two groups we are very sensitive about and will spend money and time trying to get the best care available. Any day, really, this company could drop a bombshell and the avalanche begins.
Quote:
THESE are the times that try men’s souls. The summer soldier and the sunshine patriot will, in this crisis, shrink from the service of their country; but he that stands it now, deserves the love and thanks of man and woman.
Hope for the best, Prepare for the worst. Adapt - Improvise - Overcome

"Sic parvis magma" - Greatness from small beginnings

All the best, WBeacham

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

8x8, Inc. Achieves Earnings Beat with Strong Future Guidance

Updated Category News Views 91

8x8, Inc. Reports Strong Earnings Amid Growth Initiatives 8x8, Inc. (NASDAQ: EGHT), the prominent cloud communications provider, has experienced a notable uptick of 2% in its share value during after-hours trading following the release of their latest quarterly earnings. The company reported second quarter results that exceeded market expectations, providing a boost in...

Continue Reading
Investors Can Take Action in Indivior PLC Fraud Case Today

Updated Category News Views 73

Investors Encouraged to Join Indivior PLC Securities Fraud Lawsuit The Schall Law Firm, a well-known litigation firm dedicated to protecting shareholders' rights, is reaching out to investors about an important class action lawsuit against Indivior PLC (NASDAQ: INDV). This case concerns potential breaches of the Securities Exchange Act of 1934 and Rule 10b-5 as...

Continue Reading
McDermott Expands Board with New Strategic Leaders

Updated Category News Views 286

McDermott Strengthens Leadership with New Board Appointments McDermott International, Ltd has made a significant strategic move by announcing the addition of two accomplished professionals, Michael Martino and Farhad Nanji, to its Board of Directors. This change is aimed at bolstering the company’s leadership as it navigates the complex landscapes of the energy...

Continue Reading
United Therapeutics Achieves Record Stock Price of $366.23

Updated Category News Views 52

United Therapeutics Reaches New Heights in Stock Value United Therapeutics Corporation (NASDAQ: UTHR) has achieved a remarkable milestone by reaching an all-time high of $366.23. This significant increase signifies a robust period of growth for the biotech company, which has seen its stock jump by an impressive 54.22% over the past year. The surge is largely attributed to...

Continue Reading
DoorDash Surges to New Heights as Growth Strategies Flourish

Updated Category News Views 303

DoorDash Reaches New Stock Heights DoorDash (NASDAQ: DASH) has experienced a remarkable surge, with its stock recently hitting a 52-week high of $181.78. This leap signifies not only a thriving business model but also a considerable increase in investor confidence in the food delivery service. With a market cap of $75.3 billion, DoorDash has shown impressive growth with a...

Continue Reading